Detalhe da pesquisa
1.
Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID-19 endemicity.
J Med Virol;
95(12): e29285, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38054545
2.
Short-Term Effectiveness of Oral Nirmatrelvir/Ritonavir Against the SARS-CoV-2 Omicron Variant and Culture-Positive Viral Shedding.
J Korean Med Sci;
38(8): e59, 2023 Feb 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36852855
3.
A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus.
J Med Virol;
92(9): 1665-1670, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32330296
4.
CD83 expression regulates antibody production in response to influenza A virus infection.
Virol J;
17(1): 194, 2020 12 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33302987
5.
A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model.
Int J Mol Sci;
19(7)2018 Jul 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29987260
6.
Prophylactic effect of a peptide vaccine targeting TM4SF5 against colon cancer in a mouse model.
Biochem Biophys Res Commun;
435(1): 134-9, 2013 May 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23624388
7.
Can nirmatrelvir/ritonavir treatment shorten the duration of COVID-19 isolation?
Front Med (Lausanne);
9: 988559, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36314031
8.
Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection.
Biomol Ther (Seoul);
29(3): 273-281, 2021 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33504682
9.
MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection.
BMB Rep;
54(8): 425-430, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33832550
10.
Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit.
Biomol Ther (Seoul);
29(3): 282-289, 2021 May 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33424013
11.
Discovery of New Potent anti-MERS CoV Fusion Inhibitors.
Front Pharmacol;
12: 685161, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34149429
12.
MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein.
Theranostics;
11(8): 3853-3867, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33664866
13.
Abdominal and Pelvic Organ Failure Induced by Intraperitoneal Influenza A Virus Infection in Mice.
Front Microbiol;
11: 1713, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32765481
14.
Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers.
Biomol Ther (Seoul);
28(4): 311-319, 2020 Jul 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32126736
15.
Gomisin G Suppresses the Growth of Colon Cancer Cells by Attenuation of AKT Phosphorylation and Arrest of Cell Cycle Progression.
Biomol Ther (Seoul);
27(2): 210-215, 2019 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29902863
16.
Production of a Monoclonal Antibody Targeting the M Protein of MERS-CoV for Detection of MERS-CoV Using a Synthetic Peptide Epitope Formulated with a CpG-DNA-Liposome Complex.
Int J Pept Res Ther;
25(3): 819-826, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32214929
17.
Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex.
BMB Rep;
52(6): 397-402, 2019 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30355437
18.
Peritoneal Cells Mediate Immune Responses and Cross-Protection Against Influenza A Virus.
Front Immunol;
10: 1160, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31191534
19.
Erratum to "Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers" [Biomol Ther 28(4), 311-319 (2020)].
Biomol Ther (Seoul);
32(2): 262-265, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38412977
20.
Erratum to "Gomisin G Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing AKT Phosphorylation and Decreasing Cyclin D1" [Biomol.Ther. 26 (2018) 322-327].
Biomol Ther (Seoul);
26(5): 520, 2018 09 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30157617